EZH2 and lymphoma: Inhibits EZH2-EED interaction leading to reduced H3K27me3, as well as degradation of PRC2 core subunits. DC-PRC2in-01 inhibits PRC2-driven lymphomas cell growth and demonstrates cell cycle arrest at G0/G1 phase